| Nome |
# |
|
Cathepsin L in metastatic bone disease: therapeutic implications, file e3ad8915-b867-da0e-e053-3705fe0a2b96
|
470
|
|
Follistatin as potential therapeutic target in prostate cancer, file e3ad8916-2fb1-da0e-e053-3705fe0a2b96
|
341
|
|
The role of histamine in doxorubicin and teniposide-induced cardiotoxicity in dog and mouse, file e3ad8923-09af-da0e-e053-3705fe0a2b96
|
273
|
|
Vitamin D in cancer chemoprevention, file e3ad8924-40d6-da0e-e053-3705fe0a2b96
|
189
|
|
Influence of flavonoids on the transmembrane electron transport:study ex-vivo, file e3ad8917-92bf-da0e-e053-3705fe0a2b96
|
161
|
|
Differential expression levels of urokinase-type plasminogen activator and cathepsin D in locally advanced laryngeal squamous cell carcinoma: Clinical implications, file e3ad8923-1b38-da0e-e053-3705fe0a2b96
|
156
|
|
Lenograstim in preventing chemotherapy-induced febrile neutropenia in patients with soft tissue sarcoma, file e3ad8916-2d00-da0e-e053-3705fe0a2b96
|
147
|
|
Nutrition, obesity and hormones, file e3ad8921-7ccd-da0e-e053-3705fe0a2b96
|
144
|
|
Selenium and Autoimmune Thyroiditis, file e3ad891e-e7e8-da0e-e053-3705fe0a2b96
|
125
|
|
Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma, file e3ad8916-772d-da0e-e053-3705fe0a2b96
|
109
|
|
3,5-DIIODO-L-THYRONINE-INDUCED MODIFICATION IN PITUITARY-THYROID AXIS IN RATS FED HIGH-FAT DIET. A PRELIMINARY REPORT, file e3ad8917-0113-da0e-e053-3705fe0a2b96
|
90
|
|
Follistatin as potential therapeutic target in prostate cancer, file e3ad8917-1395-da0e-e053-3705fe0a2b96
|
87
|
|
Influence of quercetin and luteolin on the activity of the catalase: study ex vivo about erythrocytes in smokers and non-smokers, file e3ad8917-925c-da0e-e053-3705fe0a2b96
|
83
|
|
Effects of 3,5-diiodo-L-thyronine on the liver of high fat diet fed rats, file e3ad8923-0edf-da0e-e053-3705fe0a2b96
|
79
|
|
Activin A circulating levels in patients with bone metastasis from breast or prostate cancer, file e3ad8917-15e1-da0e-e053-3705fe0a2b96
|
66
|
|
Adipokines in obesity and metabolic diseases, file e3ad8925-c158-da0e-e053-3705fe0a2b96
|
57
|
|
TP53 mutations and S-Phase fraction are independent prognostic indicators in locally advanced laryngeal squamous cell carcinoma, file e3ad8916-00ca-da0e-e053-3705fe0a2b96
|
56
|
|
MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone., file e3ad891d-96f4-da0e-e053-3705fe0a2b96
|
55
|
|
Circulating cathepsin K and cystatin C in patients with cancer related bone disease: Clinical and therapeutic implications, file e3ad8917-10d2-da0e-e053-3705fe0a2b96
|
41
|
|
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers, file e3ad8917-1414-da0e-e053-3705fe0a2b96
|
39
|
|
Cathepsin D expression levels in nongynecological solid tumors: Clinical and therapeutic implications, file e3ad8917-11b5-da0e-e053-3705fe0a2b96
|
34
|
|
Effects of zoledronic acid on proteinase plasma levels in patients with bone metastases., file e3ad8915-eeb6-da0e-e053-3705fe0a2b96
|
28
|
|
Effects of E-64 (cysteine-proteinase inhibitor) and Pepstatin (aspartyl-proteinase inhibitor) on metastasis formation in mice with mammary and ovarian tumors, file e3ad8923-1102-da0e-e053-3705fe0a2b96
|
24
|
|
Effects of Oleuropein on colon cancer progression in vitro. A preliminary report, file e3ad8922-e9d8-da0e-e053-3705fe0a2b96
|
22
|
|
Bioactive effects of citrus flavonoids and role in the prevention
of atherosclerosis and cancer, file 2664f841-e80f-413f-ae0c-a750a37e5664
|
19
|
|
null, file e3ad8917-11b6-da0e-e053-3705fe0a2b96
|
16
|
|
Lenograstim in preventing chemotherapy-induced febrile neutropenia in patients with soft tissue sarcoma, file e3ad891e-62bc-da0e-e053-3705fe0a2b96
|
9
|
|
Clinical Impact of Cystatin C/Cathepsin L and Follistatin/Activin A Systems in Breast Cancer Progression: A Preliminary Report, file e3ad891a-0ad8-da0e-e053-3705fe0a2b96
|
8
|
|
Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma, file e3ad8919-5121-da0e-e053-3705fe0a2b96
|
4
|
|
On the role of cystatin C in cancer progression, file e3ad891d-04eb-da0e-e053-3705fe0a2b96
|
4
|
|
Tumor markers in urogynaecological tumors., file e3ad891e-d645-da0e-e053-3705fe0a2b96
|
4
|
|
Flavonols and flavan-3-ols as modulators of xanthine oxidase and manganese superoxide dismutase activity, file e3ad8919-08e9-da0e-e053-3705fe0a2b96
|
3
|
|
Current status and future directions in the treatment of bone metastases from breast cancer, file e3ad8920-20bb-da0e-e053-3705fe0a2b96
|
3
|
|
Cathepsin D: A possible biochemical marker for anthracycline cardiomyopathy, file e3ad8923-09b0-da0e-e053-3705fe0a2b96
|
3
|
|
Antimetastatic activity of adriamycin in combinations with proteinase inhibitors in mice, file e3ad8923-0de2-da0e-e053-3705fe0a2b96
|
3
|
|
Lysosomal alterations in heart and liver of mice treated with doxorubicin, file e3ad8923-32e2-da0e-e053-3705fe0a2b96
|
3
|
|
Cathepsin L in normal and pathological bone reodeling, file e3ad8915-db5e-da0e-e053-3705fe0a2b96
|
2
|
|
Cathepsin D content in colorectal cancer, file e3ad8922-f065-da0e-e053-3705fe0a2b96
|
2
|
|
Pepstatins: Aspartic proteinase inhibitors having potential therapeutic applications, file e3ad8923-0650-da0e-e053-3705fe0a2b96
|
2
|
|
Kinetics of in vivo inhibition of tissue cathepsin d by pepstatin A, file e3ad8923-4b77-da0e-e053-3705fe0a2b96
|
2
|
|
Membrane gangliosides and immuno-mediated cytolysis in drug sensitive and treatment-induced multidrug resistant human ovarian cancer cells, file e3ad8923-4be4-da0e-e053-3705fe0a2b96
|
2
|
|
Cathepsin D, B and L circulating levels as prognostic markers of malignant progression, file e3ad8923-4c5b-da0e-e053-3705fe0a2b96
|
2
|
|
Acute myocardial effects of mitoxantrone in the rabbit, file e3ad8923-4c65-da0e-e053-3705fe0a2b96
|
2
|
|
Haemopoietic effects of 7 alpha, 17 beta Dimethyltestosterone, file e3ad8923-4c66-da0e-e053-3705fe0a2b96
|
2
|
|
Serum interleukin-6 in patients with metastatic bone disease: correlation with cystatin C., file e3ad8915-9540-da0e-e053-3705fe0a2b96
|
1
|
|
Serum follistatin in patients with prostate cancer metastatic to the bone, file e3ad8915-b148-da0e-e053-3705fe0a2b96
|
1
|
|
Cathepsin L in metastatic bone disease: therapeutic implications, file e3ad8915-ffa9-da0e-e053-3705fe0a2b96
|
1
|
|
The Role of Vitamin K in Bone Remodeling and Osteoporosis, file e3ad8916-1339-da0e-e053-3705fe0a2b96
|
1
|
|
Different Behaviour of Plasma Antioxidant Status after Red Wine
Consumption in Subjects of the Same Sex: A Preliminary Report, file e3ad8916-14be-da0e-e053-3705fe0a2b96
|
1
|
|
Flow cytometric DNA analysis and lysosomal cathepsins b and l in locally advanced laryngeal cancer. Relationship with clinicopathologic parameters and prognostic significance, file e3ad8922-f062-da0e-e053-3705fe0a2b96
|
1
|
|
Lysosomal aspartic and cysteine proteinases serum levels in patients with pancreatic cancer or pancreatitis, file e3ad8922-f068-da0e-e053-3705fe0a2b96
|
1
|
|
Effects of amsacrine (m-AMSA) a new aminoacridine antitumor drug, on the rabbit heart, file e3ad8922-fdfe-da0e-e053-3705fe0a2b96
|
1
|
|
Characterization of the metastatic properties of two methylcholantrene-induced fibrosarcoma in mice, file e3ad8923-02c3-da0e-e053-3705fe0a2b96
|
1
|
|
Stefin A and cathepsin B and L circulating serum levels in patients with malignant or non-malignant liver diseases: A preliminary report, file e3ad8923-0648-da0e-e053-3705fe0a2b96
|
1
|
|
The potential of cystatin C as a predictive biomarker in breast cancer, file e3ad8923-0d03-da0e-e053-3705fe0a2b96
|
1
|
|
Cathepsin D Serum Mass Concentrations in Patients with Hepatocellular Carcinoma and/or Liver Cirrhosis, file e3ad8923-1837-da0e-e053-3705fe0a2b96
|
1
|
|
Cathepsin D activity levels in colorectal cancer: Correlation with cathepsin B and L and other biological and clinical parameters, file e3ad8923-267b-da0e-e053-3705fe0a2b96
|
1
|
|
Biological characterization of laryngeal squamous-cell carcinoma, file e3ad8923-3005-da0e-e053-3705fe0a2b96
|
1
|
|
Cathepsin D in the malignant progression of neoplastic diseases, file e3ad8923-32ec-da0e-e053-3705fe0a2b96
|
1
|
|
Lysosomal Cathepsins B and L and Stef in A Blood Levels in Patients with Hepatocellular Carcinoma and/or Liver Cirrhosis: Potential Clinical Implications, file e3ad8923-4520-da0e-e053-3705fe0a2b96
|
1
|
|
Effects of oleuropein on tumor cell growth and bone remodelling: Potential clinical implications for the prevention and treatment of malignant bone diseases, file e3ad8923-4b0c-da0e-e053-3705fe0a2b96
|
1
|
| Totale |
2.988 |